Pulmonx Corporation

Patents = 87

Trademarks = 16

Forward Citations = 2,699

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

55 inventors (with patents filed for the assignee):

Pulmonx Corporation is a medical device company that develops minimally invasive solutions for patients with severe emphysema. Their groundbreaking Zephyr Endobronchial Valve (EBV) treatment helps to improve lung function and quality of life for patients suffering from this progressive and debilitating disease. With over a decade of clinical research and experience, Pulmonx is dedicated to providing innovative and effective solutions for emphysema patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com